Johnson & Johnson (J&J) has announced that it has ended its clinical trial for its experimental HIV vaccine, following disappointing results showing that the jab was ineffective at preventing HIV infections.
The vaccine was tested among gay men and transgender people and was found to be safe, however data showed that the jab offered no extra protection against HIV when compared to the placebo group.
